Search research articles
Contact Us
Filters
Showing results (81-90 of 115) with videos related to
Page
of 12
Sort By:
BMC Cancer
|
June 6, 2014
Perioperative rehabilitation in operation for lung cancer (PROLUCA) - rationale and design
Maja S Sommer, Karen Trier, Jette Vibe-Petersen, et al.
Acta Oncologica (Stockholm, Sweden)
|
November 7, 2023
Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan
Morten Mau-Sørensen, Jonas Gerner-Rasmussen, Olfred Hansen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 1, 2020
<sup>64</sup>Cu-DOTATATE PET/CT and Prediction of Overall and Progression-Free Survival in Patients with Neuroendocrine Neoplasms
Esben Andreas Carlsen, Camilla Bardram Johnbeck, Tina Binderup, et al.
Integrative Cancer Therapies
|
May 7, 2016
Perioperative Rehabilitation in Operable Lung Cancer Patients (PROLUCA): A Feasibility Study
Maja S Sommer, Karen Trier, Jette Vibe-Petersen, et al.
Cancers
|
March 28, 2024
Responses to Medical Treatment in 192 Patients with Pancreatic Neuroendocrine Neoplasms Referred to the Copenhagen Neuroendocrine Tumour Centre in 2000-2020
Sofie Skovlund Petersen, Stine Møller, Cecilie Slott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2015
64Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with 111In-DTPA-Octreotide in 112 Patients
Andreas Pfeifer, Ulrich Knigge, Tina Binderup, et al.
Journal of Neuroendocrinology
|
March 19, 2026
Controversies in neuroendocrine neoplasms: An European Neuroendocrine Tumor Society position statement on the role of surgery of the primary tumour in metastatic small intestinal and pancreatic neuroendocrine tumours
Stefano Partelli, Detlef K Bartsch, Massimo Falconi, et al.
Medical Oncology (Northwood, London, England)
|
March 8, 2018
Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
Abir Salwa Ali, Malin Grönberg, Seppo W Langer, et al.
Plos One
|
February 12, 2015
Goblet cell carcinoids: characteristics of a Danish cohort of 83 patients
Ingrid Holst Olsen, Nanna Holt, Seppo W Langer, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
May 15, 2018
Repeatability of FDG PET/CT metrics assessed in free breathing and deep inspiration breath hold in lung cancer patients
Lotte Nygård, Marianne C Aznar, Barbara M Fischer, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 115) with videos related to
Sort By:
Page
of 12
BMC Cancer
|
June 6, 2014
Perioperative rehabilitation in operation for lung cancer (PROLUCA) - rationale and design
Maja S Sommer, Karen Trier, Jette Vibe-Petersen, et al.
Acta Oncologica (Stockholm, Sweden)
|
November 7, 2023
Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan
Morten Mau-Sørensen, Jonas Gerner-Rasmussen, Olfred Hansen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 1, 2020
<sup>64</sup>Cu-DOTATATE PET/CT and Prediction of Overall and Progression-Free Survival in Patients with Neuroendocrine Neoplasms
Esben Andreas Carlsen, Camilla Bardram Johnbeck, Tina Binderup, et al.
Integrative Cancer Therapies
|
May 7, 2016
Perioperative Rehabilitation in Operable Lung Cancer Patients (PROLUCA): A Feasibility Study
Maja S Sommer, Karen Trier, Jette Vibe-Petersen, et al.
Cancers
|
March 28, 2024
Responses to Medical Treatment in 192 Patients with Pancreatic Neuroendocrine Neoplasms Referred to the Copenhagen Neuroendocrine Tumour Centre in 2000-2020
Sofie Skovlund Petersen, Stine Møller, Cecilie Slott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2015
64Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with 111In-DTPA-Octreotide in 112 Patients
Andreas Pfeifer, Ulrich Knigge, Tina Binderup, et al.
Journal of Neuroendocrinology
|
March 19, 2026
Controversies in neuroendocrine neoplasms: An European Neuroendocrine Tumor Society position statement on the role of surgery of the primary tumour in metastatic small intestinal and pancreatic neuroendocrine tumours
Stefano Partelli, Detlef K Bartsch, Massimo Falconi, et al.
Medical Oncology (Northwood, London, England)
|
March 8, 2018
Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
Abir Salwa Ali, Malin Grönberg, Seppo W Langer, et al.
Plos One
|
February 12, 2015
Goblet cell carcinoids: characteristics of a Danish cohort of 83 patients
Ingrid Holst Olsen, Nanna Holt, Seppo W Langer, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
May 15, 2018
Repeatability of FDG PET/CT metrics assessed in free breathing and deep inspiration breath hold in lung cancer patients
Lotte Nygård, Marianne C Aznar, Barbara M Fischer, et al.
Page
of 12